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INTRODUCTION
Polychlorinated dibenzo-p -dioxins (PCDDs) and
polychlorinated dibenzo-furans (PCDFs) are a group
of toxic chemical substances that are produced un-
intentionally during thermal and industrial processes,
such as incineration of wastes, production of organic
chlorinated herbicides and bleaching of papers (1).
Humans are exposed to low levels of PCDDs/PCDFs
through food, water, the atmosphere and soil even in
the absence of occupational or accidental exposure.
Because of their lipophilic and persistent nature,
PCDDs/PCDFs are accumulated in various organs
of wild animals and the human body, in adipose tissue
and liver in particular, through the food chain. The
toxic and biochemical responses induced by PCDDs/
PCDFs include carcinogenicity, endocrine, reproductive,
neurobehavioral and immune effects, and induction
of drug metabolizing enzymes such as CYP1A1(1).
PCDDs/PCDFs are considered to exert their toxic
effects through a common mechanism mediated
through the aryl hydrocarbon receptor (AhR) (bind-
ing to AhR, formation of heterodimers with AhR nu-
clear translocator [ARNT] in the nucleus and binding
to the xenobiotic response element and regulation of
the expression of various genes). The strength of the
toxicity of PCDDs/PCDFs is expressed relative to
that of 2,3,7,8-tetrachlorodibenzo-p -dioxin (TCDD)
using the Toxic Equivalency Factor (TEF, with the
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TEF of 2,3,7,8-TCDD=1)(2,3). Polychlorinated biphen-
yls (PCBs) are another group of persistent anthro-
pogenic organic pollutants. Although their production
and use in open systems was banned in the early
1970’s, PCBs are ubiquitously detected in various
tissues of wildlife and the human body. Some forms
of PCBs with coplanar structures (coplanar-non-ortho
and mono-ortho PCBs [co-PCBs]) have toxicities similar
to that of 2,3,7,8-TCDD. So far, TEFs have been es-
timated for 7 PCDDs, 10 PCDFs and 12 co-PCBs.
In 1998, the WHO set the tolerable daily intake
(TDI) of PCDDs/PCDFs/co-PCBs (dioxins or dioxin-
related compounds) as 1-4 pg Toxicity Equivalents
(TEQ)/kg/day (4). The TDI is definedas themaximum
daily intake of an undesirable toxic substance that
would not lead to the development of adverse health
effects with lifetime exposure. The TDI of dioxins was
calculated on the basis of the following equation, using
the lowest body burden of animals at which adverse
developmental and/or reproductive effects have been
observed (5,6), the biological half-life (7.5 years) and
absorption rate (50%) of dioxins, and the safety factor
of 10(4).
Intake (ng/kg/day)=Body Burden (ng/kg) × (ln
[2]/biological half-life)/(absorption rate)
At present, except in special populations with heavy
exposure, the mean or median intake levels among
the general populations of various countries are con-
sidered to be below the TDI, as discussed later. How-
ever, it is of concern to researchers whether there are
subtle adverse health effects of PCDDs/PCDFs/PCBs
among human populationsevenatbackgroundexposure
levels. Here we review epidemiologic studies dealing
with the dietary intake and the body burden of dioxin-
related compounds and their potential adverse health
effects, especially increased risk of diabetes mellitus
or endometriosis, and alterations of thyroid function
or the neurodevelopment of infants, at the current
background exposure levels. Effects on cancer risk
were excluded because the association may not be
strong (standardized mortality ratio for all cancers
combined=1.6) even among a population whose ex-
posure level is two to three orders ofmagnitude higher
than the general population (7).
Dietary intake of PCDDs/PCDFs/co-PCBs
Evaluation of dietary intake is crucial in the exposure
assessment of dioxin-related compounds becausemore
than 90% of exposure occurs via foods. Two methods
have been used to estimate the dietary intake among
populations, i.e., the market basket method and the
duplicate portion analysis. In the former method,
the dietary intake is estimated based on the dioxin
content in various food samples (usually measured
by high resolution gas chromatography/mass spec-
trometry [GC/MS]), and multiplied by the average
or individual consumption of corresponding foods,
which is derived from nutrition surveys. In the latter
method, the respondents of the survey prepare two
sets of identical meals, and one of them is directly
analyzed for dioxin content.
Table 1 presents the mean or median dietary intake
of PCDDs/PCDFs (8-19) and PCDDs/PCDFs/co-PCBs
(14,16,17,20-26), expressed as pg TEQ/kg/day or pg
TEQ/day, among adults, children and breast-fed
infants in various countries. All studies but two (17,
25) were based on themarket basketmethod. It should
be pointed out that some researchers did not analyze
all 29 congeners/isomers of PCDDs/PCDFs/co-PCBs
for which TEFhave been assigned. In addition, different
(Nordic, International, WHO1994, 1998) TEFs and
body weights were used to calculate dioxin intake.
Despite these methodological differences, except in
one Spanish study with high PCDDs/PCDFs intake
(19), the mean or median intake of dioxins among
adults of most countries ranged from 0.33 to 3.57 pg
TEQ/kg/day, which is lower than the maximum TDI
set by the WHO in 1998 (4 pg TEQ/kg/day)(4).
It has been reported that in mostWestern countries,
dioxin intake originated from various foods, such as
meat, meat products, milk, dairy products and fish,
whereas in Japan, Finland and Norway, the dioxin
intake, especially co-PCBs, was predominantly derived
from fish and fish products (16, 23). Although Japanese
people consume large amounts of fish, thedietary intake
of dioxins seems not to be higher than inWesterncoun-
tries (Table 1).
One problem that should be addressed is that the
distribution (variance or standard deviation) of dioxin
intake remains unknown, or reflected only that of the
short-term intake in most previous reports. Usually,
the short-term intake exhibits larger variance than the
long-term intake because it contains not only between-
subject variation but also within-subject variation (27).
Therefore, use of short-term intake may lead to over-
estimation of the proportion of subjects whose dioxin
exposure is higher than the TDI. Inone study (24), how-
ever, the 95th percentile of the dioxin intake was es-
timated at 2.0 pg TEQ/kg/day by using repeatedmeas-
urements on the same individuals and statistically ac-
counting for the within-person variance. Such an ap-
proach may be useful for clarifying the distribution
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of the long-term intake, which is necessary for risk
assessment of dioxins.
In contrast to adults, breast-fed babies have an ex-
tremely high dioxin intake. Based on the dioxin content
in breast milk and the volume of milk consumed daily,
the dioxin intake among breast-fed babies was esti-
mated at 26-170 pg TEQ/kg/day (11, 20-22), which is
much higher than the TDI. However, currently it is
not recommended to refrain from breast-feeding, con-
sidering the relatively short duration of exposure and
the overall merits of breast-feeding, such as immu-
nologic protection, nutrition andmother-to-infant bond-
ing. Several researchers reported that after the 1970’s-
1980’s the content of PCDDs/PCDFs/PCBs in breast
milk sharply declined in developed countries (28,29).
Blood levels of PCDDs/PCDFs/co-PCBs and related
factors
The body burden of dioxins can be assessed by
measuring dioxin levels in blood lipid. However, the
relationship of the blood levels with the total body
burden and the concentrations in various organsmay
be influenced by factors such as the presence of severe
weight loss (28) and hyperlipidemia, and percent body
fat. Table 2 presents the mean or median dioxin con-
centrations in the blood among populations with no
known accidental or occupational exposure (17, 30-39).
Within the same population, the arithmetic mean is
usually higher than the median, since the distribution
of the blood levels of dioxins is positively skewed.
As was the case for dietary intake, some reports did
not analyze all 29 congeners/isomers of PCDDs/
PCDFs/co-PCBs with known TEFs, and not all stud-
ies used the same TEFs. The mean or median blood
levels of PCDDs/PCDFs ranged from 9.8 to 40.8 pg
TEQ/g lipid, and the mean or median blood contents
of PCDDs/PCDFs/co-PCBs ranged from16 to43.8
pg TEQ/g lipid, with co-PCBs accounting for approxi-
mately 40% of the total TEQs.
Several researchers investigated the factors asso-
ciated with the blood levels of dioxins. In general,
blood concentrations of dioxins increase with age
(28,32,38,40). Serum levels of triglyceride were posi-
tively correlated with levels of dioxins in the blood
not only in heavily exposed populations (41,42) but also
in the general population, evenwhen expressed as pg
TEQ/g lipid (38), which suggests that dioxins aremore
concentrated in triglyceride than other fractions of
blood lipid. In Japan, serum levels of ω-3 polyunsatu-
rated fatty acids (eicosapentaenoic acid and docosa-
hexaenoic acid), a biomarker of fish intake, and intake
frequency of raw fish were reported to be positively
Table 1. Estimated mean dietary intake of dioxin-related compounds in adults, children and breast-fed babies in various countries
Country pg TEQ/kg/day pg TEQ/day Year of survey References
PCDDs+PCDFs
US
Germany
Germany
Germany
Germany
Germany
New Zealand
Venetia
Japan
Japan
Belgium
Spain
Spain
PCDDs+PCDFs+PCBs
Netherlands
UK
UK
US
US
Norway
New Zealand
Japan
Japan
Belgium
Netherlands
0.52-2.57
1.3
2 (breast-fed infants 149)
1.2
0.88
1.60 (children 14-47 mo. old)
0.18-0.44
0.89
0.47
1.00
1(median), 2(95 percentile)
(breast-fed infants 26-110)
2.4(breast-fed infants 39-170)
1.16-3.57
2.2-2.4(breast-fed infants 42)
0.33-0.76
2.25
1.3
2.04
1.2(median), 1.9(90 percentile)
93.5
85
14.5-30.6
42
44.69
65.3
210
63.8
140
137-190
112.61
132.9
1995
1984-88
1993-1996
1998
1994-1996
1999-2000
2002
2000-2001
1996
2002
1987-88
1992
1992
1995
1995
1992-194
1999-2000
2002
2000-2001
1998-99
Shecter, et al .(1996)
Beck, et al .(1989)
Beck, et al .(1992)
F¨urst, et al .(1990)
Rainer, et al .(1998)
Wittsiepe, et al .(2000)＊
Buckland, et al .(1998)
Zanotto, et al .(1999)
Tsutsumi, et al .(2001)
Ministry of Environment (2003)＊
Focant, et al .(2002)
Domingo, et al .(1999)
Bocio, et al .(2005)
Theelen, et al .(1993)
Wearne, et al (1996)
Harrison, et al .(1998)
Shecter, et al (1996)
Shecter, et al (2001)
Becher, et al .(1998)
Buckland, et al .(1998)
Tsutsumi, et al .(2001)
Ministry of Environment (2003)＊
Focant, et al .(2002)
Barrs, et al .(2004)
* Duplicate portion analysis. All other studies are based on the market basket method.
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associated with the total TEQs (38). In a Taiwanese
population living in the vicinity of waste incinerators
(mean PCDDs/PCDFs in blood=14-16 pg TEQ/g lipid),
intake frequency of sea fish, sea food and canned fish
over the previous 10 years was positively associated
with higher blood levels of PCDDs/PCDFs (40). A
survey conducted by the Japanese Ministry of the
Environment (17) showed that median blood level
of PCDDs/PCDFs/co-PCBs among persons living
in dioxin-polluted areas in Osaka and Saitama Prefec-
tures was 27 pg TEQ/g lipid, which was not signifi-
cantly different from that of the control population (23
pg TEQ/g lipid), suggesting that the contribution of
air/soil pollution to the total body burden of dioxins
was small. Among women, a larger number of breast-
fed children and longer duration of breast-feeding
were associated with lower levels of PCDDs/PCDFs/
co-PCBs in the blood (28). Regarding the host factors,
single nucleotide polymorphism of the CYP1A1 gene
was not associated with total TEQs in blood (39). It
has been reported that dioxin levels in blood have been
gradually decreasing with time in developed countries
(28,32).
The reference range or upper normal limit for the
blood levels of dioxins has not been determined. One
reason for this may be that the association between
exposure to low levels of PCDDs/PCDFs/co-PCB
and health effects has not been definitely established.
Another approach may be to estimate these values on
the basis of the statistical distribution. In Japan, the
95th percentile of the blood levels of dioxins was around
65 pg TEQ/g lipid (17).
Potential health effects associated with low levels of
exposure to PCDDs/PCDFs/PCBs
Diabetes mellitus
The association between dioxins and diabetes was
firstly reported for occupationally exposed populations
and subsequently investigated in the general population.
In a longitudinal studywithmore than 20 years of follow-
up, Henriksen et al. (43) found that the risk of diabetes
significantly increased, and time to diabetes onset sig-
nificantly decreased, among U.S. Air Force veterans
who had been heavily exposed to Agent Orange and
its contaminant, 2,3,7,8-TCDD, during the Vietnam
War (serum2,3,7,8-TCDD=10-618pg/g lipid). In a cross-
sectional study on chemical workers heavily exposed
to 2,4,5-trichlorophenol (2,4,5-T) (National Institute for
Occupational Safety andHealth [NIOSH] cohort), the
prevalence of diabetes among the exposed group
(N=280, mean serum 2,3,7,8 -TCDD=220 pg/g lipid)
was not significantly different from that of the control
group (N=260, mean=7pg/g lipid). However, six of
10 workers with the highest serum 2,3,7,8 -TCDD
levels (＞1500 pg/g lipid) had diabetes (44). In a study
by Steenland et al .(45), in which the data from the
U.S. Air Force veterans (43) and the NIOSH cohort
(44) were re-analyzed, a dose-response relationship
between serum dioxin and prevalence of diabetes
was observed only for Air Force veterans.
Longnecker et al .(46) reported that there was a
significant dose-response relationship between the
serum level of 2,3,7,8 -TCDD and the prevalence of
diabetes among 1,197 Air Force veterans with no
history of occupational dioxin exposure. The preva-
lence odds ratio of diabetes in the highest quartile
Table 2. Blood levels of dioxin-related compounds (pg TEQ/g lipid) in general populations of various countries
Country No. of subjects Mean or median Range Year of survey References
PCDDs+PCDFs
Canada
Canada
Germany
Germany
Finland
Spain
Japan
Japan
Japan
Japan
Japan
PCDDs+PCDFs+PCBs
Canada
Canada
Japan
Japan
Japan
Japan
pooled sample
30
139
507
45
28
50
50
253
8
259
pooled sample
30
39
253
8
259
14.6(mean)
20.6(mean)
16.1(mean)
19.2-40.8(median)
32(median)
27.6(mean)
16.4(mean)
17.2-22.9(median)
9.8(median)
20.2(mean)
14(median)
26.1(mean)
36.3(mean)
21(mean)
16-17(median)
43.8(mean)
23(median)
6.1-113.6
12.0-81.0
13.4-84.0
10.9-48.7
0.91-33
0.61-56
9.1-37
1.3-53
1.6-110
1992
1994
1996
1991-6
1998
1999
1993-4
1998
1999
2000
2002
1992
1994
1993-4
1999
2000
2002
Ayotte et al .(1997)
Ryan et al .(1997)
P¨apke et al .(1998)
Wittsiepe et al .(2000)
Kiviranta et al .(2000)
Domingo et al .(2001)
Iida et al .(1999)
Kumagai et al .(2000,2002)
Arisawa et al .(2003)
Tsuchiya et al .(2003)
Ministry of Environment(2003)
Ayotte et al .(1997)
Ryan et al .(1997)
Iida et al .(1999)
Arisawa et al .(2003)
Tsuchiya et al .(2003)
Ministry of Environment(2003)
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(＞5.2 pg/g lipid) was 1.71 (95% CI 1.00-2.91) as com-
pared with the lowest quartile (＜2.8 pg/g lipid). How-
ever, after adjustment for serum triglycerides, a po-
tential confounder, the odds ratio was attenuated
to 1.56 (95% CI 0.91-2.67). The same research group
also reported higher serum levels of PCBs among
pregnant women with diabetes than among controls
(47). However, because these two studies were cross-
sectional, it remains unclear whether exposure to 2,
3,7,8-TCDD/PCBs increased the prevalence of dia-
betes, or diabetes altered the metabolism of 2,3,7,8-
TCDD/PCBs in the body. Considering all these find-
ings taken together, it seems premature to conclude
that exposure to background levels of dioxins increases
the risk of diabetes. In the future, cohort studies of
populations with background levels of exposure will
be required.
Endometriosis
The association between exposure to dioxin-related
compounds and endometriosis was firstly found in
animal experiments, and subsequently investigated
in highly exposed human populations, followed by
general populations. Endometriosis is important in
that this is one of the most sensitive adverse effects
observed in animal experiments, and has been used
as a basis for the calculation of TDI (4). In 1993, Rier
et al . (5) reported that the incidence and the severity
of endometriosis increased in a dose-dependent man-
ner in rhesus monkeys fed a diet containing 5-25 ppt
of 2,3,7,8-TCDD for 4 years. An additional study con-
ducted 13years after the terminationof exposureshowed
that serum levels of not only 2,3,7,8-TCDD but also
dioxin-like PCBs (International Union for Pure and
Applied Chemistry [IUPAC] No.77 and 126) were in-
creased in TCDD-treated monkeys, especially among
those with endometriosis, suggesting the involvement
of dioxin-like PCBs in the development of the disease
(48).
In Seveso, Italy, where heavy exposure to 2,3,7,8-
TCDD occurred because of an explosion at a chemical
plant, a historical cohort study was carried out (49).
Among 601 women, 19 cases of endometriosis were
identified during 20 years of follow-up. Themultivari-
ate relative risks for women with 2,3,7,8-TCDD levels
of ＞100 ppt and 20.1-100 ppt were 2.1(95% CI 0.5-8.0)
and 1.2 (95%CI 0.3-4.5), respectively, as comparedwith
women with ＜=20 ppt. It was pointed out that non-
differential misclassification of disease status, because
of inability to perform laparoscopy for every woman,
may have led to the underestimation of relative risks
(49).
Several case-control studies have been performed
on populations without accidental or occupational
exposure. An Israeli study (50) reported that 2,3,7,8-
TCDD was detected in 8/44(18%) of women with
endometriosis, as comparedwith 1/35 (3%) of control
women. The odds ratio associated with high blood
2,3,7,8-TCDD levels was estimated at 7.6(95%CI 0.87-
169.7). However, the limitation of this study was that
statistical power was lacking, and only 2,3,7,8-TCDD
but no other congeners/isomers were analyzed. In
a Belgian study involving 42 cases and 27 controls
with mechanical infertility (51), there were no signifi-
cant differences in the blood levels of total TEQs, as
determined by the chemical-activated luciferase gene
expression (CALUX)-bioassay, or of one co-PCB (No.
118) or three non-coplanar PCBs (No.138,153 and
180). On the other hand, when a cut-off point of 100
pg-TEQ/g lipid was used, the odds ratio of endometri-
osis was elevated but not significantly (4.56, 95%CI
0.48-43.6). In a recent small case-control study (23
cases and 17 controls) performed inBelgium and Italy,
there was no significant difference in the total TEQs
in blood between cases and controls (52). Thus, at
present it is not clear whether exposure to background
levels of dioxins increases the risk of endometriosis.
In the future, larger epidemiologic studies with sufficient
statistical power will be required. For instance, if the
true odds ratio is 2-3, an unmatched case-control study
would require 99-282 women for both cases and con-
trols, assuming that the prevalence of endometriosis
among the source population is 10% and α and β are
set to 0.05(two-tailed) and 0.20, respectively (53).
Thyroid function
In animal experiments, exposure to PCDDs/PCDFs,
and PCBs or their hydroxylatedmetabolites influences
the hypothalamo-pituitary-thyroidaxisbyvariousmecha-
nisms (54), although the direction of the effects may
vary according to the animal species (55). Inratsexposed
to 2,3,7,8-TCDD or PCBs, serum thyroxine (T4) de-
creased and secretion of thyroid stimulating hormone
(TSH) from the pituitary increased. Exposure to 2,3,
7,8,-TCDD or co-PCBs induced the enzymeT4-uridine
diphosphoglucuronyl-transferase-1 (UDPGT-1) in
the liver by an Ah-receptor-mediated mechanism and
thereby increased hepatic glucuronidation and biliary
excretion of T4 (56-58). It has also been shown that
hydroxylated PCBs and PCDDs/PCDFs have higher
affinity than T4 for the transthyretin (thyroxine-binding
prealbumin), the major T4 transport protein in the
plasma of rodents, which may lead to the inhibition
of the T4 transportation to the brain (59). In fetal rats,
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T4 levels in the forebrain and cerebellum decreased
following maternal exposure to PCBs, thoughT3 levels
remained unchanged because of compensatory induc-
tion of type II 5’-deinodinase (60).
In humans, data about the association between ex-
posure to dioxin-related compounds and thyroid func-
tion have been inconsistent for both adults and infants,
though the blood levels of T4, free T4 and TSH are
generally within the normal range even in heavily
exposed subjects. Ott et al . (61) reported that serum
T4 and thyroxine-binding globulin (TBG) levels sig-
nificantly increased with increasing current TCDD
concentrations in the blood among 138 members of
the BASF cohort who had been heavily exposed to
2,4,5-T and 2,3,7,8-TCDD. Among 281 U.S. workers
exposed to 2,4,5-T, there was also a significant increase
in the free T4 index but no change in the serumTSH
level (44). On the other hand, in 16 patients with Yusho,
there was no association between total TEQ and serum
concentrations of triiodothyronine (T3), T4, free T4
or TSH 27 years after the outbreak, despite extremely
high TEQs in the blood (median=222.4 pg/g fat)(62).
Pavuk et al . (63) reported that there was no difference
in the serum T4 levels or T3 % uptake betweenUSAir
Force veterans who had been heavily exposed to
TCDD (median blood TEQ=45.7 pg/g fat) and control
Air Force veterans. However, the serum levels of TSH
were significantly higher in the exposed group.
In a Dutch study of pregnant womenwith no known
accidental or occupational exposure (mean PCDDs/
PCDFs/co-PCBTEQ in the breastmilk=74.9pgTEQ/g
lipid), serum levels of T4 andT3 significantly decreased
as the dioxin levels in the breast milk increased (64).
In contrast, among Australian men exposed to very
low levels of 2,4,5 -T (mean serum 2,3,7,8-TCDD=2.6-
8.1 ppt), serum levels of TSH (Spearman r=-0.4) but
not T4 were significantly and negatively correlated
with TCDD(65).
In infants, two studies, one conducted in the Neth-
erlands (at 2 weeks of age)(64) and the other in Japan
(at 1 year of age)(66), found that decreased serum
T4 levels were related to high TEQ levels in breast
milk. In contrast, there were increased blood levels
of total T4, T4/TBG ratio and TSH among infants
(aged 11 weeks) with high PCDDs/PCDFs TEQs in
another Dutch study (67). In another Japanese study,
there were no differences in the blood levels of T4,
T3, free T4 or TSH between breast-fed and bottle-fed
infants aged 1 year (68). The reason for the discrepancy
among these studies remains unknown ; however,
the decreased T4 and the increased TSH levels in the
blood of infants reported by Koopmann-Esseboom
et al .(64) were consistent with those of experimental
studies on rats (56,57). Since thyroid hormones are
essential for normal brain development during fetal
and neonatal periods, some researchers proposed the
decreased serum T4 levels observed among pregnant
women (64) and infants (64,66) as one of the possible
mechanisms linking exposure to PCBs/dioxins and
impaired neurodevelopment of children, as discussed
below.
Neurodevelopment of infants
The association between exposure to PCDDs/
PCDFs/PCBs and neurodevelopment of infants has
been reported mainly in relation to non-dioxin-like
PCBs (69). An impairment of neuropsychological de-
velopment was reported among Taiwanese children
born to mothers who had been accidentally exposed
to high levels of PCBs and other thermally degraded
substances, including PCDFs, through contaminated
rice oil (70). Animal experiments also showed that
PCBs have direct toxic effects on neurotransmission
and neural network formation that are not mediated
Table 3. Effects of dioxin exposure on thyroid function in adults and infants
Population No. of subjects Mean exposure level (pg/g lipid) T4 free T4 TSH References
Adults
BASF cohort (Germany)
US(2,4,5-T exposed)
Yusho patients
US Air Force veterans
Netherlands (pregnant women)
Australia(2,4,5-T exposed)
Infants
Netherlands(0-11 weeks)
Netherlands(2 weeks)
Japan(1 year)
Japan(1 year)
138
281
16
275
78
37
15
39
37
337
＜1-553＊(blood, 2,3,7,8-TCDD)
220(blood, 2,3,7,8-TCDD)
222.4(blood, TEQ)
45.7(blood, 2,3,7,8-TCDD)
74.9(milk, TEQ)
2.6-8.1(blood,2,3,7,8-TCDD)
37.5(milk, TEQ)
72.4(milk, TEQ)
25.7(milk, TEQ)
13.1-29.5(milk, TEQ)
↑
↑
⇔
⇔
↓
⇔
↑
↓
↓
⇔
↑
⇔
⇔
↑＊＊
⇔
⇔
⇔
⇔
⇔
⇔
↑
⇔
↓
↑
↑
⇔
⇔
Ott, et al .(1994)
Calvert, et al .(1999)
Nagayama, et al .(2001)
Pavuk, et al .(2003)
Koopman-Esseboom, etal.(1994)
Johnson, et al .(2001)
Plium, et al .(1993)
Koopman-Esseboom, et al.(1994)
Nagayama, et al .(1996)
Matsumura, et al .(2001)
＊ range, ＊＊ T4/TBG ratio.
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by Ah-R (71). Cohort studies have also been conducted
on children born tomothers who had consumed PCBs-
contaminated fishes from Lake Michigan (72) and
Lake Ontario (73), and contaminated whale meat and
blubber from the Faroe Islands (74). However, these
studies on accidental (70) or environmental exposure
(72-74) were excluded from this review because the
exposure levels of PCBs in such studies may be
higher than the levels in the general population.
Several longitudinal studies in the U.S.(75-78), the
Netherlands (79-84) andGermany (85,86) investigated
the effects of background exposure to PCBs or dioxins
on mental and psychomotor development of infants
(Table 4). In North Carolina, U.S., approximately 900
pairs of mothers and infants were initially enrolled,
and total PCBs in breast milk (0 week) wasmeasured
as an index of prenatal exposure. The median total
PCB concentration in the breast milk at birth was
reported to be 1,770 ng/g lipid (75). However, this
value may be overestimated because of the old ana-
lytical method used (69). No PCDDs/PCDFs conge-
ners/isomers in breast milk were analyzed. There was
no association between prenatal PCBs exposure and
weight or head circumference at birth. However, high
exposure was associated with hypotonicity and hy-
poreflexia, as assessed by the Neonatal Behavioral
Assessment Scale (NBAS)(76). The Bayley Psycho-
motor Scales were decreased at 6,12 and 24 months
in relation to high transplacental exposure, but not
postnatal exposure through breast milk (77,78). No
effects on mental development were observed.
In theNetherlands cohort, approximately 400mother-
Table 4. Effects on growth and neurodevelopment associated with exposure to PCBs and/or PCDDs/PCDFs/co-PCBs
Cohort No. ofsubjects Age Exposure variables Effects References
North Carolina
Netherlands
Germany
912
802
676
670
207
209
207
418
395
394
171
171
0 m
6 m
12 m
18 m
24 m
0 m
0-3 m
3-42 m
0 m
3 m
7 m
18 m
18 m
42 m
42 m
7 m
30 m
42 m
Prenatal total PCBs exposure
(Breast milk(0 w) total PCBs)
Prenatal total PCBs exposure
Prenatal total PCBs exposure
Prenatal total PCBs exposure
Cord PCBs, maternal PCBs
Cord PCBs, maternal PCBs
Cord PCBs, maternal PCBs
Breast milk PCBs(2 w)
Breast milk total TEQ(2 w)
Maternal plasma PCBs
Breast milk total PCBs-dioxins TEQ
(postnatal exposure)
Perinatal PCBs, total TEQs
Postnatal PCBs, total TEQs
Cord PCBs, maternal PCBs
Maternal plasma PCBs
Maternal plasma PCBs
Cord plasma PCBs
42 mo. plasma PCBs
Breast milk(2,4 w) PCB 138,153,180
Breast milk(2 w) PCB 138,153,180
(prenatal exposure)
Breast milk(2w) PCB 138,153,180
Milk PCBs x duration of breast-feeding
42 mo. plasma PCBs
Birth weight⇔
Head circumference⇔
NBAS tonicity↓
NBAS reflexes↓
Bayley Scales psychomotor↓
Bayley Scales psychomotor↓
Bayley Scales mental⇔
Bayley Scales psychomotor⇔
Bayley Scales mental⇔
Bayley Scales psychomotor↓
birth weight↓
growth rate↓
growth rate⇔
Prechtl neurological
optimality score↓(hypotonic)
Bayley Scales psychomotor↓
Bayley Scales psychomotor↓
Bayley Scales mental, psychomotor⇔
Bayley Scales mental, psychomotor⇔
Prechtl Neurological
Optimality score↓
Kaufman Assessment
Battery for Children
Overall cognitive↓
Sequential↓
Simultaneous↓
Towen/Hampel
Neurological condition⇔
Bayley Scales mental↓motor⇔
Fagan visual recognition memory⇔
Bayley Scales mental↓
Bayley Scales motor↓
Kaufman mental development↓
Kaufman mental development↓
Kaufman mental development↓
Rogan, et al .(1986)
Gladen, et al .(1988)
Rogan, et al .(1991)
Patandin, et al .(1998)
Huisman, et al .(1995a)
Koopman
-Esseboom, et al.(1996)
Huisman, et al .(1995b)
Patandin, et al .(1999)
Lanting, et al .(1999)
Winneke, et al .(1998)
Walcowiak, et al.(2000)
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infant pairs, 200each in Groningen and Rotterdam,
were enrolled (79). Umbilical cord plasma andmaternal
plasma PCBs (No.118,138,153 and 180) were meas-
ured as an index of prenatal exposure, and PCDDs/
PCDFs/PCBs content in breast milk (at 2 weeks)
multiplied by the number of weeks of breast-feeding
was used as an index of lactational exposure to these
substances. The median total PCBs concentration
in cord plasma, maternal plasma and breast milk
was 0.40µg/l, 2.04µg/l and 391.5ng/g lipid, respec-
tively, and the median total PCDDs/PCDFs/co-PCBs
in breast milk was 64.8 pg TEQ/g lipid. Prenatal PCBs
exposure was inversely associated with birth weight
and growth rate during 0-3 months (change in weight,
length and head circumference)(79). There were also
negative effects on motor and cognitive development,
as assessed by Bayley Psychomotor Scales at 3 and
7 months (80) and Kaufman Assessment Battery for
Children at 42 months (81), respectively, mainly in
relation to prenatal PCBs and partly in relation to post-
natal PCDDs/PCDFs/co-PCBs exposure. On the other
hand, breast-feeding itself had a positive effect on the
Bayley Psychomotor Scales at 7 months. The Prechtl
Neurological Optimality Score at 0 month decreased
as the combined pre-and early neonatal exposure (both
dioxin-like and non-dioxin-like PCBs, and PCDDs/
PCDFs/co-PCBs-TEQ in breast milk at 2 weeks) in-
creased (82). The same score at 18 months decreased
as the prenatal PCBs exposure (cord and maternal
PCBs) increased (83). At 42 months, there was no sig-
nificant association between PCBs or PCDDs/PCDFs/
co-PCBs exposure and neurological condition as as-
sessed by the Towen/Hempel method (84). There
was no significant relationship between the serum
thyroid hormone levels and the mental or psycho-
motor development at any age (80).
¨In Dusseldorf, Germany, 171 healthy mother-infant
pairs were initially recruited (85). The sumof the levels
of three non-dioxin-like PCBs (No.138, 153 and 180)
in breast milk (at 2 weeks) were used as an index of
prenatal exposure, and milk PCBs multiplied by du-
ration of breast-feeding and plasma levels of PCBs
in infants were used as an index of postnatal exposure.
The median total PCBs concentration in cord plasma
and breast milk was 0.39 µg/l and 404 ng/g lipid, re-
spectively. No PCDDs/PCDFs concentrations in cord
plasma or breast milk were analyzed. A negative as-
sociation was observed between prenatal exposure
and neurodevelopment, as assessed by the Bayley
Mental/Motor Scales of Infant Development at 30
months and the Kaufman Assessment Battery for
Children (simultaneous and sequential information
processing) at 42months, after adjustment for vari-
ous potential confounders, including smoking, alcohol
drinking and parental education (86). There was also
an inverse association between postnatalPCBsexposure
and Kaufman Assessment Battery for Children at 42
months. On the other hand, a good home environment
compensated for the adverse effects of PCBs exposure.
In summary, inhibitory effects on motor and mental
development of infants have been observed in relation
to background exposure to PCBs/dioxins, especially
trans-placental PCBs, although there are some incon-
sistencies in the exposure media and outcome vari-
ables. The lack of significant association between
serum thyroid hormone levels and mental/motor
development (80) suggests the involvement of non-
thyroid-mediated mechanisms. At all events, efforts
should be made to further decrease exposure levels
among women of reproductive age as much as pos-
sible, by reducing the release of PCDDs/ PCDFs/
PCBs into the environment. In the future, longitudinal
studies of the neurodevelopment of infants should
be performed on fish-eating populations such as the
Japanese, because fish is a major source of exposure
to dioxin-like and non-dioxin-like PCBs.
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